Related Experiment Video
Updated: Mar 26, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
One SNP at a Time: Moving beyond GWAS in Psoriasis
Helen Ray-Jones1, Stephen Eyre2, Anne Barton3
1Arthritis Research UK Centre for Genetics and Genomics, Centre for Musculoskeletal Research, Institute of Inflammation and Repair, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom; The Dermatology Centre, Salford Royal NHS Foundation Trust, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom.
Genome-wide association studies (GWAS) identified psoriasis genetic risk loci, but the specific variants, pathways, and cell types remain unclear. This review explores methods to understand how these genetic factors increase psoriasis risk.
Area of Science:
- Immunogenetics
- Dermatology
- Genomics
Background:
- Genome-wide association studies (GWAS) have identified numerous genetic risk loci associated with psoriasis.
- However, the specific causal variants, biological pathways, and key cell types underlying these associations are largely uncharacterized.
- A deeper understanding is crucial for elucidating psoriasis pathogenesis.
Purpose of the Study:
- To review current approaches for characterizing genetic risk loci in psoriasis.
- To elucidate how identified genetic loci contribute to an increased risk of developing psoriasis.
- To bridge the gap between genetic associations and biological mechanisms in psoriasis.
Main Methods:
- Literature review of studies investigating genetic risk loci in psoriasis.
- Analysis of current methodologies used to functionally annotate GWAS findings.
- Synthesis of research on variant identification, pathway analysis, and cell-type-specific contributions.
Main Results:
- Current research focuses on pinpointing causal variants within associated loci.
- Investigating the involvement of specific biological pathways (e.g., immune response, skin barrier function).
- Identifying the primary immune or structural cell types implicated in psoriasis pathology.
Conclusions:
- Further investigation is needed to functionally validate identified genetic risk loci.
- Understanding the precise mechanisms linking genetic predisposition to psoriasis development is essential.
- This knowledge will pave the way for targeted therapeutic strategies.
More Related Videos
08:27Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization
Published on: July 27, 2021
04:41Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Single Nucleotide Polymorphisms-SNPs
Pharmacogenomics: Identification of New Drug Targets
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Principles of Pharmacogenetics: Types of Genetic Variants
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu